NCT05180071尚未招募不适用
A Post-market Study Evaluating Clinical and Radiographic Outcomes of Total Elbow Arthroplasty With TEMA
Limacorporate S.p.a0 个研究点目标入组 59 人开始时间: 2024年2月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 59
- 主要终点
- Oxford Elbow Score improvement at three ears FU
研究概览
简要总结
TEMA elbow system is a CE marked medical device, and within this clinical trial it is used according to its intended use. This is a Post Marketing Clinical Follow Up trial, with the main aim to collect evidences on the outcome data on this product, by analysing clinical scoring systems, radiographs and adverse event records within five years after the surgery, and thus to assess the short-term performance and safety of this implant.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient's age ≥ 18 years old.
- •Patient has given written informed consent to participate to the trial and to his/her personal data processing
- •According to the device indications for use, patient suffers from disability due to one or more of the following:
- •Elbow joint destruction which significantly compromises the activities of daily living
- •Non-Inflammatory degenerative joint disease including osteoarthritis and avascular necrosis with hemophilia.
- •Rheumatoid arthritis or degenerative arthritis with incapacitating pain
- •Correction of severe functional deformity.
- •Treatment of acute or chronic fractures with distal humerus epicondyle involvement.
- •Post-traumatic lesions or bone loss contributing to elbow instability or loss of motion
- •Any other medical reason that the investigator determine that subject is a good candidate for a total elbow arthroplasty
- •Patient has undergone a total elbow arthroplasty, receiving TEMA prosthesis.
- •Patient is able to comply with the study protocol.
排除标准
- •A patient will be excluded from the study participation if he/she meets any of the following criteria:
- •Patient is affected by one or more of the conditions that are stated as TEMA contraindications for use, which are:
- •Local or systemic infection;
- •Septicemia;
- •Persistent acute or chronic osteomyelitis.
- •Uncooperative patient or patient with neurologic disorders who are incapable of following directions;
- •Osteoporosis;
- •Metabolic disorders which may impair bone formation;
- •Rapid joint destruction, marked bone loss or bone resorption.
- •Patient suffers from a diaphyseal fracture
- •For female patients, current pregnancy and/or lactation or planning a pregnancy.
- •Only for patients implanted with the unlinked configuration of TEMA prosthesis, the intraoperative testing showed a bad quality of medial and lateral elbow ligaments.
- •Patient is enrolled in another investigational drug/device study that in the opinion of the Investigator could interfere with this clinical trial
结局指标
主要结局
Oxford Elbow Score improvement at three ears FU
时间窗: 2 years Follow up
Functional change in Oxford Elbow Score (OES) from preoperative (baseline) to 2 years of follow-up.
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Hip Arthroplasty With Logica Mirror Femoral StemHip ReplacementNCT05003739Limacorporate S.p.a47
Unknown
不适用
CP009 SYNERGOSS PXX ObservationalMouth, EdentulousNCT02775058Nobil Bio Ricerche srl22
已完成
不适用
A Study of a Mobile Phone Application Measuring the Eyes Before and After MedicationSubstance Use Disorder (SUD)NCT06629740Kontigo Care AB34
已完成
不适用
Study to Examine Clinical Performance and Safety of Cutimed® Gelling Fiber in Routine Clinical PracticeLeg UlcerSurgical WoundAbrasionBurn, Partial ThicknessOncology WoundPressure UlcerLacerationDiabetic Foot UlcerNCT05148390BSN Medical GmbH36
进行中（未招募）
不适用
REDUCE LAP-HF III Corvia Protocol 1701Heart FailureNCT03191656Corvia Medical500